99 related articles for article (PubMed ID: 22705356)
1. Novel MDM2 splice variants identified from oral squamous cell carcinoma.
Sam KK; Gan CP; Yee PS; Chong CE; Lim KP; Karen-Ng LP; Chang WS; Nathan S; Rahman ZA; Ismail SM; Cheong SC
Oral Oncol; 2012 Nov; 48(11):1128-35. PubMed ID: 22705356
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing.
Huang SF; Chen IH; Liao CT; Wang HM; Liou SH; Hsieh LL
Oral Oncol; 2009 Jan; 45(1):16-22. PubMed ID: 18487080
[TBL] [Abstract][Full Text] [Related]
3. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation.
Tu HF; Chen HW; Kao SY; Lin SC; Liu CJ; Chang KW
Radiother Oncol; 2008 May; 87(2):243-52. PubMed ID: 18423915
[TBL] [Abstract][Full Text] [Related]
4. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
5. Impact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma risk.
Xie JL; Yang JL; Liu DS; Xie YG; Ji P
Cell Biochem Biophys; 2015 Mar; 71(2):993-8. PubMed ID: 25323564
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma.
Chen X; Sturgis EM; Lei D; Dahlstrom K; Wei Q; Li G
Cancer Res; 2010 Sep; 70(18):7199-208. PubMed ID: 20736372
[TBL] [Abstract][Full Text] [Related]
7. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
8. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
9. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
10. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
Chen Q; Fu J; Yang G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):337-40. PubMed ID: 9592286
[TBL] [Abstract][Full Text] [Related]
11. MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset.
Hamid S; Yang YH; Peng KN; Ismail SM; Zain RB; Lim KP; Wan Mustafa WM; Abraham MT; Teo SH; Cheong SC
Oral Oncol; 2009 Jun; 45(6):496-500. PubMed ID: 18804411
[TBL] [Abstract][Full Text] [Related]
12. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
14. ORAOV1-A correlates with poor differentiation in oral cancer.
Jiang L; Yang HS; Wang Z; Zhou Y; Zhou M; Zeng X; Chen QM
J Dent Res; 2009 May; 88(5):433-8. PubMed ID: 19493886
[TBL] [Abstract][Full Text] [Related]
15. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.
Oliveira Alves M; Balducci I; Rodarte Carvalho Y; Cabral L; Nunes F; Almeida J
Oral Dis; 2013 Nov; 19(8):775-80. PubMed ID: 23350884
[TBL] [Abstract][Full Text] [Related]
18. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
19. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
20. Frequency of p53 gene mutation and protein expression in oral squamous cell carcinoma.
Ara N; Atique M; Ahmed S; Ali Bukhari SG
J Coll Physicians Surg Pak; 2014 Oct; 24(10):749-53. PubMed ID: 25327920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
